US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Ongoing

Pain Wizard

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0528-2024
Class II · Moderate risk Ongoing

Natural Pain Relieving Cream

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0527-2024
Class II · Moderate risk Ongoing

Natural Pain Relieving Cream

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0526-2024
Class II · Moderate risk Ongoing

Pain Wizard

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0525-2024
Class II · Moderate risk Ongoing

Pain Wizard

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0524-2024
Class II · Moderate risk Ongoing

Aloe Gator

Reason Out of Specification for active ingredient

ARG Laboratories, Inc. D-0523-2024
Class II · Moderate risk Ongoing

Natural Pain Relieving Cream

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0521-2024
Class II · Moderate risk Ongoing

Pain Wizard

Reason Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

ARG Laboratories, Inc. D-0520-2024
Class II · Moderate risk Completed

Gordofilm Wart Remover

Reason cGMP Deviations

Dercher Enterprises, Inc., DBA Gordon Laboratories NDC 10481-3009-01 D-0495-2024
Class II · Moderate risk Terminated

Eyesaline

Reason CGMP Deviations

Honeywell INC D-0461-2024
Class II · Moderate risk Ongoing

Isotretinoin Capsules

Reason Superpotent Drug: The 3-month stability result for assay was found to be above specification limit

Teva Pharmaceuticals USA, Inc NDC 0591-2436-45 D-0439-2024
Class II · Moderate risk Ongoing

Diltiazem Hydrochloride Extended-Release Capsules

Reason Failed Dissolution Specifications: Out of Specification (OOS) was reported in test of dissolution at the 12th month time point in long term stability study.

Glenmark Pharmaceuticals Inc., USA NDC 68462-562-01 D-0430-2024
Class II · Moderate risk Completed

Methylergonovine Maleate Tablets

Reason Failed Dissolution Specifications

Amneal Pharmaceuticals of New York, LLC NDC 69238-1605-2 D-0477-2024
Class II · Moderate risk Ongoing

fentaNYL Citrate 2

Reason Lack of Assurance of Sterility: leaking bags

IntegraDose Compounding Services LLC NDC 71139-6030-1 D-0432-2024
Class II · Moderate risk Terminated

Lactated Ringer's Injection USP

Reason Lack of assurance of sterility: bags have the potential to leak..

B. Braun Medical Inc NDC 0264-7750-00 D-0431-2024
Class II · Moderate risk Terminated

Rifampin Capsules USP

Reason Subpotent Drug

Lupin Pharmaceuticals Inc. NDC 6818-0659-06 D-0437-2024
Class II · Moderate risk Terminated

VCF Vaginal Contraceptive Film

Reason cGMP Diviations

Apothecus Pharmaceutical Corp. NDC 52925-112-01 D-0427-2024
Class II · Moderate risk Completed

Sterile Diluent

Reason CGMP Deviations

Eli Lilly & Company D-0445-2024
Class II · Moderate risk Ongoing

Infumorph

Reason The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.

Hikma Pharmaceuticals USA Inc. NDC 0641-6039-01 D-0392-2024
Class II · Moderate risk Terminated

Tri-Lo-Sprintec

Reason Failed Dissolution Specifications

Teva Pharmaceuticals USA, Inc NDC 0093-2140-62 D-0428-2024